ArticleOncotarget2015

Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma.

David J Duffy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.